In Vivo RNAi Efficacy of Palmitic Acid-Conjugated Dicer-Substrate siRNA in a Subcutaneous Tumor Mouse Model

Chemical Biology & Drug Design
Takanori KuboToshio Seyama

Abstract

Short interfering RNAs are used in RNA interference technology and are powerful tools for target gene silencing in a sequence-specific manner. In this study, we synthesized Dicer-substrate siRNAs consisting of 27-nt double-stranded RNAs conjugated with palmitic acid at the 5'-end of the sense strand and investigated their RNA interference efficacies in vitro and in vivo. The palmitic acid-conjugated 27-nt DsiRNAs (C16-Dsi27RNAs) were prepared by our simple synthesis strategy and achieved a good yield. C16-Dsi27RNAs showed enhanced in vitro RNA interference potency compared with not only non-modified Dsi27RNAs but also cholesterol-conjugated Dsi27RNAs against both an exogenous enhanced green fluorescent protein and the endogenous vascular endothelial growth factor gene in a human scirrhous-type gastric cancer cell line that stably expressed the enhanced green fluorescent protein gene (GCIY-eGFP). Additionally, C16-Dsi27RNAs had potent gene silencing activity against both enhanced green fluorescent protein and vascular endothelial growth factor as target genes in a subcutaneous tumor mouse model generated from GCIY-eGFP cells administered by intratumoral injection. These results suggest that the C16-Dsi27RNAs will be useful next-...Continue Reading

References

Feb 20, 2003·Nature Biotechnology·Jason W MyersJames E Ferrell
May 20, 2003·Nature Biotechnology·Aimee L JacksonPeter S Linsley
May 20, 2004·Cancer Research·Yoshifumi TakeiTakashi Muramatsu
Sep 3, 2004·Bioorganic & Medicinal Chemistry Letters·Christina LorenzCarlo Unverzagt
Nov 13, 2004·Nature·Jürgen SoutschekHans-Peter Vornlocher
Dec 28, 2004·Nature Biotechnology·Dong-Ho KimJohn J Rossi
Jul 29, 2005·Nucleic Acids Research·Scott D RoseMark A Behlke
Aug 11, 2005·Nucleic Acids Research·Xiaoyu LinYu Shen
Jan 28, 2006·Journal of Cellular Biochemistry·Wei-Hua Pan, Gary A Clawson
Sep 18, 2007·Nature Biotechnology·Christian WolfrumMarkus Stoffel
Mar 26, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Kazutaka NishinaTakanori Yokota
Jul 22, 2008·Oligonucleotides·Michael A CollingwoodMark A Behlke
Dec 5, 2008·Bioconjugate Chemistry·Ji Hoon JeongTae Gwan Park
Nov 17, 2010·The FEBS Journal·Min Suk Shim, Young Jik Kwon
Feb 9, 2011·The Journal of Organic Chemistry·Takeshi YamadaKallanthottathil G Rajeev
Oct 12, 2011·Molecular Pharmaceutics·Takanori KuboToshio Seyama
Nov 8, 2011·Biomacromolecules·Siew Ching KowVolga Bulmus
Jan 13, 2012·Bioconjugate Chemistry·Takanori KuboToshio Seyama
Mar 1, 2012·Bioconjugate Chemistry·Mouna RaouanePatrick Couvreur
Jun 1, 2012·ACS Chemical Biology·Armando R HernándezEric T Kool
Sep 18, 2012·Biochemical and Biophysical Research Communications·Takanori KuboToshio Seyama
Sep 18, 2012·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Takanori KuboToshio Seyama
Jul 26, 2013·Therapeutic Delivery·Johannes Winkler
Oct 24, 2013·Nature Materials·Rosemary KanastyDaniel Anderson
Mar 29, 2014·Expert Opinion on Drug Delivery·Christoffer NielsenNiels Behrendt
Jan 10, 2013·ACS Medicinal Chemistry Letters·Maria GaglioneAnna Messere
May 21, 2015·Journal of Biomedical Nanotechnology·Sathish DyawanapellyRatnesh Jain
Apr 1, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Kazutaka NishinaTakanori Yokota

❮ Previous
Next ❯

Citations

Dec 19, 2018·Chemical Biology & Drug Design·Takanori KuboToshio Seyama
Jan 17, 2019·Experimental Dermatology·Stefano ColomboAdam Bohr

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.